Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment

This study has been withdrawn prior to enrollment.
(difficulty in recruiting parients)
Sponsor:
Information provided by:
The Baruch Padeh Medical Center, Poriya
ClinicalTrials.gov Identifier:
NCT01414829
First received: August 10, 2011
Last updated: December 2, 2012
Last verified: December 2012
  Purpose

Gastric biopsies will be taken to compare different methods of H.pylori disclosure.Standard methods will be compared to culture.


Condition Intervention
Other Diseases or Conditions | Patient
Procedure: Gastroscopy

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Efficacy of Gastric Biopsy for Culture and Antibiotic Sensitivity Assessment and Comparing of Different Methods for Helicobacter Pylori Disclosure

Resource links provided by NLM:


Further study details as provided by The Baruch Padeh Medical Center, Poriya:

Biospecimen Retention:   Samples Without DNA

gastric biopsies


Enrollment: 0
Study Start Date: August 2011
Estimated Study Completion Date: January 2012
Estimated Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Intervention Details:
    Procedure: Gastroscopy
    The reason for gastroscopy will be not related to the study
  Eligibility

Ages Eligible for Study:   10 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population

Patient referred for gastroscopy because of clinical reasons

Criteria

Inclusion Criteria:

  • all referred for gastroscopy with clinical or endoscopic signs of peptic disease

Exclusion Criteria:

  • coagulation disorders
  • pregnant women
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01414829

Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Principal Investigator: Maya PAritsky, MD Baruch Padeh MC, Israel
  More Information

No publications provided

Responsible Party: Paritsky Maya, Baruch Padeh MC
ClinicalTrials.gov Identifier: NCT01414829     History of Changes
Other Study ID Numbers: paritsky1.ct.il
Study First Received: August 10, 2011
Last Updated: December 2, 2012
Health Authority: Israel: Ministry of Health

Keywords provided by The Baruch Padeh Medical Center, Poriya:
Peptic disease
Helicobacter pylori
Different methods

ClinicalTrials.gov processed this record on November 24, 2014